Why Bruker Stock Slumped Monday
(NASDAQ: BRKR) published its latest quarterly earnings report Monday morning, and despite notching a double beat the company's stock took something of a hit. Its price fell nearly 1% by the closing bell, as investors didn't take kindly to a double miss on full-year guidance. Earlier in the trading session, Bruker dipped as much as 3.9%.
Bruker, which specializes in the supply of medical devices and scientific instruments, earned revenue of almost $861 million in its third quarter. This number was down 0.5% from the same period of 2024.
Image source: Getty Images.
Source Fool.com
Bruker Corp. Aktie
55,87 €
1,82 %
Die Community neigt bei Bruker Corp. zu Buy-Einschätzungen, mit einigen mehr als Sell-Einschätzungen.
Ein unerwartetes negatives Potenzial von -6.93% für Bruker Corp., trotz eines niedrigeren Kursziels von 52 € als der aktuelle Kurs von 55.87 €.
